In xenograft mouse models, we further proved that CCL25 could effectively promote tumor growth and suppress tumor apoptosis, and this enhancement could be reduced by inhibitors of CCR9 and PI3K/AKT, indicating that the PI3K/AKT signaling pathway played a key role in CCL25/CCR9 process. The gene discussed is CCR9; the disease is neoplasm.